Fig. 1From: Feasibility and efficacy of gemcitabine and docetaxel combination chemotherapy for bone and soft tissue sarcomas: multi-institutional retrospective analysis of 134 patientsKaplan-Meier estimates of survival of all patients. a Progression-free survival. b Overall survivalBack to article page